[{"Assets_0_Q3_USD":82061000.0,"CommonStockSharesOutstanding_0_Q3_shares":24977720.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-50940000.0,"NetIncomeLoss_1_Q3_USD":-16350000.0,"NetIncomeLoss_3_Q3_USD":-52535000.0,"StockholdersEquity_0_Q3_USD":68152000.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171101"}]